查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1776201

合成橡胶帮浦的全球市场:洞察，竞争情形，市场预测:2032年

Elastomeric Pump - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

2024年，弹性体帮浦市场规模达6.6339亿美元。预计2025年至2032年期间，该市场将以6.72%的复合年增长率成长，到2032年将达到11.0914亿美元。弹性体帮浦的需求受多种关键因素驱动，其中包括癌症、糖尿病和神经系统疾病等慢性疾病的发生率不断上升。此外，全球外科手术数量的增加也增加了患者对输液治疗的需求。此外，产品开发领域的持续技术进步也提高了这些设备的有效性和便利性。这些因素共同为2025年至2032年弹性帮浦市场稳定成长奠定了坚实的基础。

弹性帮浦市场动态：

根据GLOBOCAN数据（2023年），2022年将报告约2000万例新增癌症病例，预计到2045年这一数字将增至3260万例。癌症患者数量的成长推动了对弹性化疗输液帮浦的需求。这些帮浦通常是一次性使用的，经过单独校准以确保准确一致的药物输送，使其成为门诊肿瘤治疗的必需品。

同样，全球糖尿病负担也迅速增加。根据国际糖尿病联盟 (2023) 的数据，2021 年约有 5.37 亿成年人（20-79 岁）患有糖尿病。预计到 2030 年，这一数字将增至 6.43 亿，到 2045 年将增至 7.83 亿。弹性帮浦在这一领域发挥重要作用，透过确保持续且准确的胰岛素输送，帮助在门诊和家庭环境中维持更好的血糖控制。

此外，传染病负担仍是一个主要问题。根据世界卫生组织 (2024) 的数据，估计到 2023 年，爱滋病毒感染者人数将达到 3,990 万人，其中包括 140 万名儿童（0-14 岁）和 3,860 万名成年人（15 岁及以上）。

此外，根据世界卫生组织 (WHO) (2024) 提供的数据，预计到 2023 年，全球将有 1,080 万人罹患结核病，其中包括 600 万名男性、360 万名女性和 130 万名儿童。爱滋病毒患者和类似慢性感染患者通常需要长期静脉注射抗生素治疗，而弹性泵可以透过持续输注有效地进行给药，尤其是在门诊和家庭护理环境中。

慢性疼痛管理也是一个主要的应用领域。透过弹性帮浦注射局部麻醉剂通常用于术后和慢性疼痛管理。根据欧洲疼痛联合会 (2023) 的数据，欧洲约有 1.5 亿人患有慢性疼痛。这些帮浦提供了一种有效的非电子解决方案，可长期给药，无需住院。

此外，根据世界卫生组织 (WHO) (2024) 的数据，2022 年约有 25 亿成年人（18 岁及以上）超重。其中，8.9 亿人患有肥胖症。此外，肥胖患者经常接受减重手术和其他需要术后疼痛管理的手术，而弹性帮浦通常用于持续输送止痛药。

此外，全球外科手术的增加预计将进一步刺激对弹性帮浦的需求。根据欧盟 (2023) 提供的数据，2022 年欧盟约有 110 万例剖腹产。这些帮浦将液体止痛药直接输送到手术部位，有助于控制术后疼痛。例如，根据加拿大萨斯喀彻温省政府2024年5月发布的数据，2023-24财年将进行约95,700例手术，较上一财年大幅增加。随着手术数量的持续成长，预计弹性帮浦市场也将随之成长。

然而，弹性泵的局限性和挑战，以及严格的设备审批监管要求，是可能限制弹性泵市场成长的关键限制因素。

弹性帮浦市场区隔分析

弹性帮浦市场：依产品类型（连续速度弹性输液帮浦、变速弹性输液帮浦、两者兼有）、给药途径（静脉、皮下、硬膜外、其他）、适应症（疼痛管理、抗生素治疗、化疗、其他）、最终用户（医院、门诊手术中心、家庭医疗保健、其他）和地区（北美、欧洲、亚太地区、其他）

按产品类型划分的弹性帮浦市场中，连续速度弹性输液帮浦类别预计将在 2024 年占据最大的市场占有率。这一增长主要得益于慢性病盛行率的上升，以及连续速度弹性泵在治疗和管理此类疾病方面所提供的多功能性和临床益处。

连续流速的主要优点之一弹性帮浦的优点在于其能够以预定的恆定流速输送药物，从而保持血浆中药物浓度的稳定性。这使得它们非常适合那些需要维持稳态药物浓度的治疗，例如抗生素、止痛药和化疗药物的给药。例如，弹性帮浦广泛应用于门诊肠外抗生素治疗 (OPAT)，因为它们可以实现便携式、非电子输液，无需外部电源或复杂的管路系统。由 Progressive Medical, Inc. 开发的 SMARTeZ® 抛弃式弹性帮浦就是一个典型的例子，它专为间歇性和连续性抗生素输液以及常规输液治疗而设计。

弹性帮浦设计的技术进步显着提高了其易用性、耐用性和安全性。这些创新使得泵浦的药物稳定性和保质期提高，使其能够在不影响性能的情况下进行冷藏或冷冻。这些先进设备的一个关键优势在于其内建预设流量，从而最大限度地降低了误用风险，而误用是电子输液泵常见的问题。

此外，持续作用弹性帮浦透过内部弹性球囊自行供电，无需电池或外部电源。此外，其易于维护的设计降低了机械故障的可能性，并提高了可靠性。这些特性，加上其便携性和易用性，使这些帮浦适用于各种临床环境。

这些因素预计将推动细分市场的发展，并最终扩大全球弹性泵市场。

预计北美将主导整个弹性帮浦市场：

预计到2024年，北美将占据弹性帮浦市场的最大占有率，这主要得益于几个关键因素。该地区的主导地位主要归功于慢性病盛行率的上升、高度发展的医疗基础设施以及主要市场参与者的强大影响力。综合起来，这些因素使北美成为全球弹性泵市场的领先市场。

根据国际癌症研究机构 (2025) 的数据，预计美国新增癌症病例数将从 2022 年的 2,380,189 例大幅增加到 2045 年的 3,380,124 例。其中，白血病新增病例预计将从 2022 年的 63,100 例增加到 2045 年的 88,600 例。同样，根据加拿大癌症协会 (2024) 的数据，加拿大将有超过 6,600 人被诊断出患有白血病。癌症治疗通常需要持续进行化疗、标靶治疗和免疫治疗，因此弹性输液帮浦成为癌症治疗中不可或缺的工具。

根据美国心臟协会 (2024) 的数据，超过 2,930 万成年人被诊断出患有糖尿病，但估计仍有 970 万人未确诊。此外，截至 2021 年，据报导有 1.159 亿美国人处于糖尿病前期。弹性帮浦在胰岛素治疗中发挥关键作用，它能够准确、持续地传递维持稳定血糖水平所需的剂量，尤其对于需要强化胰岛素治疗的患者而言。

此外，根据美国疾病管制与预防中心 (2023) 的数据，到 2022 年，约有 20.9% 的成年人（5,160 万人）将遭受慢性疼痛的困扰。其中，6.9%（1,710 万人）患有严重的慢性疼痛，严重限制了他们的日常活动。弹性帮浦通常用于持续输注止痛药物，如今正越来越多地被用作疼痛管理策略，尤其是对于长期忍受非癌性疼痛的患者。

此外，根据美国卫生与公共服务部 (2023) 的数据，每年约有 2,300 万美国人前往医生办公室或诊所就诊，寻求感染治疗。

除了日益加重的疾病负担外，北美还受益于先进的医疗保健基础设施，这支持了先进输液技术的广泛应用。主要医疗器材製造商和关键市场参与者的存在进一步巩固了该地区在全球弹性帮浦市场的地位。

这些因素——慢性病盛行率的上升、强劲的临床需求以及强大的医疗保健基础设施——预计将在预测期内显着推动北美弹性泵市场的成长。

弹性帮浦市场的主要参与者

弹性帮浦市场的主要参与者包括 B.Braun Melsungen AG、Baxter、Nipro Corporation、DAIKEN MEDICAL CO、Gamastech Innovative Infusion Systems、Vikymed Italia srl、PAJUNK、Ace Medical、McKesson Corporation、MULTIMEDICAL S.r.l.、Progive Medical, Medical, N.F. SRL、FLOWONIX MEDICAL INC.、Smiths Group plc、Fresenius SE & Co. KGaA、Avanos Medical, Inc. 和 Intera Oncology。

弹性体帮浦市场的最新发展：

  • 2024年5月，Arecor Therapeutics plc宣布与美敦力公司合作研发一种新型高浓度、热稳定性胰岛素，用于下一代胰岛素帮浦。透过此次合作，两家公司将在胰岛素治疗领域取得进展，透过提供减少胰岛素帮浦维护介入需求的胰岛素来改善患者照护。这可能会扩大医生的受益，并显着节省医疗成本。

合成橡胶帮浦市场调查报告书主要的要点

  • 目前弹性帮浦市场规模分析（2024 年）及八年（2025-2032 年）市场预测
  • 过去三年主要产品/技术开发、併购、合作及合资企业
  • 主导弹性帮浦市场的主要公司
  • 弹性帮浦市场竞争对手面临的各种机会
  • 2024 年的主要细分市场及其 2032 年的表现
  • 目前弹性帮浦市场 弹性帮浦市场表现最佳的地区和国家
  • 企业应关注的弹性帮浦市场未来成长机会的地区和国家

合成橡胶帮浦市场常被询问的问题

1.弹性体帮浦

  • 弹性体泵，也称为球囊泵或弹性体输液泵，是一种非电子一次性医疗器械，用于在一段时间内向患者输送定量药物。

2. 弹性体帮浦市场

  • 预计2024年弹性体帮浦市场规模将达到6.6339亿美元，2025年至2032年的复合年增长率为6.72%，到2032年将达到11.0914亿美元。

3. 弹性体帮浦市场推动因素

  • 弹性体帮浦的需求受多种关键因素驱动，其中包括癌症、糖尿病和神经系统疾病等慢性疾病的发生率不断上升。此外，家庭医疗保健也日益受到青睐，这些帮浦可帮助患者在家中接受输液治疗。此外，产品开发领域的技术进步也不断提升这些设备的效能和便利性。这些因素共同为弹性帮浦市场在2025年至2032年期间的稳健成长奠定了坚实的基础。

4.弹性体帮浦市场的主要公司

  • 弹性体帮浦市场的主要参与者包括 B.Braun Melsungen AG、Baxter、Nipro Corporation、DAIKEN MEDICAL CO、Gamastech Innovative Infusion Systems、Vikymed Italia srl、PAJUNK、Ace Medical、McKesson Corporation、MULTIMEDICAL S.r.l.、Progive Medicalr. SRL、FLOWONIX MEDICAL INC.、Smiths Group plc、Fresenius SE & Co. KGaA、Avanos Medical, Inc. 和 Intera Oncology。

5.弹性体帮浦市占率最大的地区

  • 预计到2024年，北美将占据弹性体帮浦市场的最大占有率，这主要得益于几个关键因素。该地区的主导地位主要归功于慢性病盛行率的上升、高度发展的医疗保健基础设施以及主要市场参与者的强大影响力。综合起来，这些因素使北美成为全球弹性体帮浦市场的领先市场。

目录

第1章 合成橡胶帮浦市场报告的简介

第2章 合成橡胶帮浦市场摘要整理

第3章 竞争情形

第4章 法规分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第5章 合成橡胶帮浦市场主要原因分析

  • 弹性体帮浦市场推动因素
    • 慢性病发生率上升
    • 医疗保健领域外科手术数量增加
    • 产品开发技术进步
  • 弹性体帮浦市场限制与挑战
    • 弹性帮浦的限制与挑战
    • 严格的设备审批监理要求
  • 弹性泵的市场机遇
    • 改进产品设计，提高药物输送精度
    • 家用弹性泵的扩张

第6章 合成橡胶帮浦市场波特的五力分析

第7章 合成橡胶帮浦市场评估

  • 各产品类型
    • 常用速度合成橡胶输液帮浦
    • 可变比率合成橡胶输液帮浦
    • 双方
  • 各给药途径
    • 静脉内
    • 皮下
    • 硬膜外麻醉
    • 其他
  • 各适应症
    • 疼痛管理
    • 抗生素疗法
    • 化疗
  • 各终端用户
    • 医院
    • 门诊病人手术中心
    • 居家照护
  • 各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第8章 合成橡胶帮浦市场企业与产品简介

  • B.Braun Melsungen AG
  • Baxter
  • Nipro Corporation
  • DAIKEN MEDICAL CO., LTD.
  • Gamastech Innovative Infusion Systems
  • Vikymed Italia srl
  • PAJUNK
  • Ace Medical
  • McKesson Corporation
  • MULTIMEDICAL S.r.l.
  • Progressive Medical, Inc.
  • Vygon Group
  • Promecon GmbH
  • Preferred Medical
  • Adriamed SRL
  • FLOWONIX MEDICAL INC.
  • Smiths Group plc
  • Fresenius SE & Co. KGaA.
  • Avanos Medical, Inc.
  • Intera Oncology

第9章 KOL的见解

第10章 计划方法

第11章 关于DelveInsight

第12章 免责声明和咨询方式

Product Code: DIMDCL0236

Elastomeric Pump Market by Product Type (Continuous Rate Elastomeric Infusion Pumps, Variable Rate Elastomeric Infusion Pumps, and Both), Route of Administration (Intravenous, Subcutaneous, Epidural, and Others), Indication (Pain Management, Antibiotic Therapy, Chemotherapy, and Others), End-User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the growing prevalence of chronic diseases, increasing surgical procedures, and technological advancements in product development.

The elastomeric pump market was valued at USD 663.39 million in 2024, growing at a CAGR of 6.72% during the forecast period from 2025 to 2032 to reach USD 1,109.14 million by 2032. The demand for elastomeric pumps is growing due to several key factors. These include the increasing prevalence of chronic diseases such as cancer, diabetes, and neurological conditions, and others. The increasing number of surgical procedures performed worldwide also necessitates infusion therapy for patients. Additionally, ongoing technological advancements in product development are enhancing the effectiveness and convenience of these devices. Together, these factors are creating a strong foundation for steady and robust growth in the elastomeric pump market from 2025 to 2032.

Elastomeric Pump Market Dynamics:

According to data from GLOBOCAN (2023), approximately 20 million new cancer cases were reported in 2022, a number projected to rise to 32.6 million by 2045. This increasing cancer burden underscores the rising demand for chemotherapy elastomeric infusion pumps, which are specifically designed to deliver chemotherapy medications. These pumps are typically disposable, single-use devices, individually calibrated for accurate and consistent drug delivery, making them essential in ambulatory oncology care.

Similarly, the global diabetes burden is escalating rapidly. As per the International Diabetes Federation (2023), around 537 million adults (aged 20-79) were living with diabetes in 2021. This number is expected to grow to 643 million by 2030 and 783 million by 2045. Elastomeric pumps play a crucial role in this domain by ensuring continuous and accurate insulin delivery, thereby helping to maintain better glycemic control in outpatient and home settings.

Moreover, the burden of infectious diseases remains a major concern. According to the World Health Organization (2024), an estimated 39.9 million people were living with HIV in 2023, including 1.4 million children (0-14 years) and 38.6 million adults (15+ years).

Additionally, according to the data provided by the World Health Organization (2024), in 2023, an estimated 10.8 million people fell ill with TB worldwide, including 6.0 million men, 3.6 million women, and 1.3 million children. Patients with HIV and similar chronic infections often require long-term intravenous antibiotic therapy, which elastomeric pumps can administer effectively through continuous infusion, particularly in outpatient and home-based care.

Chronic pain management is another major application area. Local anesthetic infusions delivered via elastomeric pumps are frequently used for managing post-operative and chronic pain. According to the European Pain Federation (2023), approximately 150 million people in Europe suffer from chronic pain. These pumps offer an effective, non-electronic solution for delivering pain relief medications over extended periods without the need for hospitalization.

Furthermore, according to data provided by the World Health Organization (2024), in 2022, approximately 2.5 billion adults (18 years and older) were overweight. Of these, 890 million were living with obesity. Additionally, obese patients frequently undergo bariatric surgeries and other procedures that necessitate post-operative pain management, where elastomeric pumps are commonly used to deliver analgesics continuously.

Additionally, the growing number of surgical procedures worldwide is expected to further stimulate demand for elastomeric pumps. According to the data provided by the European Union (2023), there were approximately 1.10 million caesarean sections performed in the EU in 2022. These pumps deliver liquid pain medication directly to the surgical site, helping to manage post-operative pain. For example, data published by the Government of Saskatchewan, Canada, in May 2024 revealed that approximately 95,700 surgeries were performed in the fiscal year 2023-24, representing a notable increase compared to the previous year. As surgical volumes continue to rise, the market for elastomeric pumps is expected to grow in parallel.

However, the limitations and challenges associated with elastomeric pumps and stringent regulatory requirements for device approval, among others, are some of the key constraints that may limit the growth of the elastomeric pump market.

Elastomeric Pump Market Segment Analysis:

Elastomeric Pump Market by Product Type (Continuous Rate Elastomeric Infusion Pumps, Variable Rate Elastomeric Infusion Pumps, and Both), Route of Administration (Intravenous, Subcutaneous, Epidural, and Others), Indication (Pain Management, Antibiotic Therapy, Chemotherapy, and Others), End-User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the elastomeric pump market, the continuous rate elastomeric infusion pumps category is estimated to account for the largest market share in 2024. This growth is primarily driven by the increasing prevalence of chronic diseases and the versatility and clinical advantages offered by continuous rate elastomeric pumps in the treatment and management of such conditions.

One of the key advantages of continuous rate elastomeric pumps is their ability to deliver medication at a predetermined, consistent flow rate, ensuring stable plasma drug concentrations. This makes them ideal for therapies where maintaining steady-state drug levels is crucial, such as in the administration of antibiotics, analgesics, and chemotherapy agents. For instance, elastomeric pumps are widely used in outpatient parenteral antibiotic therapy (OPAT), as they provide portable, non-electronic infusion without the need for external power sources or complex tubing systems. A notable example is the SMARTeZ(R) disposable elastomeric pump developed by Progressive Medical, Inc., designed for both intermittent and continuous antibiotic infusion as well as general infusion therapies.

Technological advancements in elastomeric pump design have significantly enhanced their usability, durability, and safety. These innovations have led to the development of pumps with extended drug stability and storage capabilities, enabling them to be refrigerated or even frozen without compromising performance. One of the key benefits of these advanced devices is the incorporation of pre-set flow rates, which help minimize the risk of incorrect dosing, a common concern with electronic infusion pumps.

Furthermore, continuous elastomeric pumps are self-powered through an internal elastic balloon, eliminating the need for batteries or external power sources. Their low-maintenance design reduces the likelihood of mechanical failure, making them highly reliable. These features, combined with their portability and ease of use, make these pumps suitable for a wide range of clinical settings.

Thus, the factors mentioned above are likely to boost the market segment and thereby increase the overall market of elastomeric pump across the globe.

North America is expected to dominate the overall elastomeric pump market:

North America is projected to hold the largest share of the elastomeric pump market in 2024, driven by several key factors. This regional dominance is primarily attributed to the rising prevalence of chronic diseases, a highly advanced healthcare infrastructure, and the strong presence of key market players. Collectively, these factors are positioning North America as the leading market in the global elastomeric pump market.

According to data from the International Agency for Research on Cancer (2025), the number of new cancer cases in the U.S. was 2,380,189 in 2022, with projections indicating a significant rise to 3,380,124 cases by 2045. Among these, leukemia had 63,100 new cases in 2022, expected to increase to 88,600 by 2045. Similarly, data from the Canadian Cancer Society (2024), over 6,600 people were diagnosed with leukemia in Canada. Cancer treatments often require continuous delivery of chemotherapy, targeted therapies, and immunotherapy, making elastomeric infusion pumps an essential tool in oncology care.

According to the American Heart Association (2024), more than 29.3 million adults have been diagnosed with diabetes, while an estimated 9.7 million remain undiagnosed. Furthermore, 115.9 million Americans were reported to be living with pre-diabetes as of 2021. Elastomeric pumps play a critical role in insulin therapy by delivering precise and continuous doses needed to maintain stable blood glucose levels, particularly in patients requiring intensive insulin regimens.

Furthermore, as per the Centers for Disease Control and Prevention (2023), approximately 20.9% of adults, or 51.6 million people, experienced chronic pain in 2022. Of these, 6.9% (17.1 million people) suffered from high-impact chronic pain that significantly limits daily activities. Elastomeric pumps, often used for continuous infusion of pain-relieving medications, are increasingly being adopted in pain management strategies, especially for patients dealing with long-term, non-cancer-related pain.

Additionally, as per the data provided by the U.S Department of Health and Human Services (2023), it was stated that about 23 million Americans visit a doctor's office or clinic seeking treatment for infections every year.

In addition to the growing disease burden, North America benefits from an advanced healthcare infrastructure, which supports the widespread adoption of advanced infusion technologies. The presence of leading medical device manufacturers and key market players further strengthens the region's position in the global elastomeric pump market.

Collectively, these factors, such as rising chronic disease prevalence, strong clinical demand, and robust healthcare infrastructure, are expected to significantly drive the growth of the North America elastomeric pump market during the forecast period.

Elastomeric Pump Market Key Players:

Some of the key market players operating in the elastomeric pump market include B.Braun Melsungen AG, Baxter, Nipro Corporation, DAIKEN MEDICAL CO., LTD., Gamastech Innovative Infusion Systems, Vikymed Italia srl, PAJUNK, Ace Medical, McKesson Corporation, MULTIMEDICAL S.r.l., Progressive Medical, Inc., Vygon Group, Promecon GmbH, Preferred Medical, Adriamed SRL, FLOWONIX MEDICAL INC., Smiths Group plc, Fresenius SE & Co. KGaA, Avanos Medical, Inc., Intera Oncology, and others.

Recent Developmental Activities in the Elastomeric Pump Market:

  • In May 2024, Arecor Therapeutics plc announced a research collaboration with Medtronic to develop a novel, high-concentration, thermostable insulin for use in a next-generation pump. Through this collaboration, both companies bring advancements in insulin treatment to enhance patient care by providing insulin that reduces the need for pump maintenance interventions. This could broaden its utility for physicians and lead to significant healthcare cost savings.

Key takeaways from the elastomeric pump market report study

  • Market size analysis for the current elastomeric pump market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the elastomeric pump market.
  • Various opportunities available for the other competitors in the elastomeric pump market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current elastomeric pump market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the elastomeric pump market growth in the future?

Target audience who can benefit from this elastomeric pump market report study

  • Elastomeric pump product providers
  • Research organizations and consulting companies
  • Elastomeric pump-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in elastomeric pumps
  • Various end-users who want to know more about the elastomeric pump market and the latest technological developments in the elastomeric pump market.

Frequently Asked Questions for the Elastomeric Pump Market:

1. What is an elastomeric pump?

  • Elastomeric pump, also known as a balloon pump or elastomeric infusion pump, is a non-electronic, disposable medical device used to deliver continuous, controlled volumes of medication to a patient over a set period of time.

2. What is the market for an elastomeric pump?

  • The elastomeric pump market was valued at USD 663.39 million in 2024, growing at a CAGR of 6.72% during the forecast period from 2025 to 2032 to reach USD 1,109.14 million by 2032.

3. What are the drivers for the elastomeric pump market?

  • The demand for elastomeric pumps is growing due to several key factors. These include the increasing prevalence of chronic diseases such as cancer, diabetes, and neurological conditions, and others. There is also a rising shift toward home healthcare, as these pumps allow patients to receive infusion therapy at home. Additionally, ongoing technological advancements in product development are enhancing the effectiveness and convenience of these devices. Together, these factors are creating a strong foundation for steady and robust growth in the elastomeric pump market from 2025 to 2032.

4. Who are the key players operating in the elastomeric pump market?

  • Some of the key market players operating in the elastomeric pump market include B.Braun Melsungen AG, Baxter, Nipro Corporation, DAIKEN MEDICAL CO., LTD., Gamastech Innovative Infusion Systems, Vikymed Italia srl, PAJUNK, Ace Medical, McKesson Corporation, MULTIMEDICAL S.r.l., Progressive Medical, Inc., Vygon Group, Promecon GmbH, Preferred Medical, Adriamed SRL, FLOWONIX MEDICAL INC., Smiths Group plc, Fresenius SE & Co. KGaA, Avanos Medical, Inc., Intera Oncology, and others.

5. Which region has the highest share in the elastomeric pump market?

  • North America is projected to hold the largest share of the elastomeric pump market in 2024, driven by several key factors. This regional dominance is primarily attributed to the rising prevalence of chronic diseases, a highly advanced healthcare infrastructure, and the strong presence of key market players. Collectively, these factors are positioning North America as the leading market in the global elastomeric pump market.

Table of Contents

1. Elastomeric Pump Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Elastomeric Pump Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Elastomeric Pump Market Key Factors Analysis

  • 5.1. Elastomeric Pump Market Drivers
    • 5.1.1. The growing prevalence of chronic diseases
    • 5.1.2. Increasing number of surgical procedures in healthcare
    • 5.1.3. Technological advancements in product development
  • 5.2. Elastomeric Pump Market Restraints and Challenges
    • 5.2.1. Limitations and challenges associated with elastomeric pumps
    • 5.2.2. Stringent regulatory requirements for device approval
  • 5.3. Elastomeric Pump Market Opportunity
    • 5.3.1. Improvements in product design for developing precision during drug delivery
    • 5.3.2. Increasing expansion of home-based elastomeric pumps

6. Elastomeric Pump Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Elastomeric Pump Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Continuous Rate Elastomeric Infusion Pumps
    • 7.1.2. Variable Rate Elastomeric Infusion Pumps
    • 7.1.3. Both
  • 7.2. By Route of Administration
    • 7.2.1. Intravenous
    • 7.2.2. Subcutaneous
    • 7.2.3. Epidural
    • 7.2.4. Others
  • 7.3. By Indication
    • 7.3.1. Pain Management
    • 7.3.2. Antibiotic Therapy
    • 7.3.3. Chemotherapy
    • 7.3.4. Others
  • 7.4. By End-User
    • 7.4.1. Hospitals
    • 7.4.2. Ambulatory Surgical Centers
    • 7.4.3. Homecare Settings
    • 7.4.4. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.1.2. Canada Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.1.3. Mexico Elastomeric Pump Market Size in USD million (2022-2032)
    • 7.5.2. Europe
      • 7.5.2.1. France Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.2.2. Germany Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.2.3. United Kingdom Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.2.4. Italy Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.2.5. Spain Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.2.6. Rest of Europe Elastomeric Pump Market Size in USD million (2022-2032)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.3.2. Japan Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.3.3. India Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.3.4. Australia Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.3.5. South Korea Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.3.6. Rest of Asia-Pacific Elastomeric Pump Market Size in USD million (2022-2032)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.4.2. Africa Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.4.3. South America Elastomeric Pump Market Size In USD Million (2022-2032)

8. Elastomeric Pump Market Company and Product Profiles

  • 8.1. B.Braun Melsungen AG
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Baxter
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Nipro Corporation
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. DAIKEN MEDICAL CO., LTD.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Gamastech Innovative Infusion Systems
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Vikymed Italia srl
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. PAJUNK
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Ace Medical
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. McKesson Corporation
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. MULTIMEDICAL S.r.l.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Progressive Medical, Inc.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Vygon Group
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Promecon GmbH
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Preferred Medical
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Adriamed SRL
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. FLOWONIX MEDICAL INC.
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Smiths Group plc
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Fresenius SE & Co. KGaA.
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Avanos Medical, Inc.
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Intera Oncology
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Elastomeric Pump Market in Global (2022-2032)
  • Table 3: Elastomeric Pump Market in Global by Product Type (2022-2032)
  • Table 4: Elastomeric Pump Market in Global by Route of Administration (2022-2032)
  • Table 5: Elastomeric Pump Market in Global by Indication (2022-2032)
  • Table 6: Elastomeric Pump Market in Global by End-User (2022-2032)
  • Table 7: Elastomeric Pump Market in Global by Geography (2022-2032)
  • Table 8: Elastomeric Pump Market in North America (2022-2032)
  • Table 9: Elastomeric Pump Market in the United States (2022-2032)
  • Table 10: Elastomeric Pump Market in Canada (2022-2032)
  • Table 11: Elastomeric Pump Market in Mexico (2022-2032)
  • Table 12: Elastomeric Pump Market in Europe (2022-2032)
  • Table 13: Elastomeric Pump Market in France (2022-2032)
  • Table 14: Elastomeric Pump Market in Germany (2022-2032)
  • Table 15: Elastomeric Pump Market in United Kingdom (2022-2032)
  • Table 16: Elastomeric Pump Market in Italy (2022-2032)
  • Table 17: Elastomeric Pump Market in Spain (2022-2032)
  • Table 18: Elastomeric Pump Market in the Rest of Europe (2022-2032)
  • Table 19: Elastomeric Pump Market in Asia-Pacific (2022-2032)
  • Table 20: Elastomeric Pump Market in China (2022-2032)
  • Table 21: Elastomeric Pump Market in Japan (2022-2032)
  • Table 22: Elastomeric Pump Market in India (2022-2032)
  • Table 23: Elastomeric Pump Market in Australia (2022-2032)
  • Table 24: Elastomeric Pump Market in South Korea (2022-2032)
  • Table 25: Elastomeric Pump Market in Rest of Asia-Pacific (2022-2032)
  • Table 26: Elastomeric Pump Market in the Rest of the World (2022-2032)
  • Table 27: Elastomeric Pump Market in the Middle East (2022-2032)
  • Table 28: Elastomeric Pump Market in Africa (2022-2032)
  • Table 29: Elastomeric Pump Market in South America (2022-2032)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Elastomeric Pump Market in Global (2022-2032)
  • Figure 3: Elastomeric Pump Market in Global by Product Type (2022-2032)
  • Figure 4: Elastomeric Pump Market in Global by Route of Administration (2022-2032)
  • Figure 5: Elastomeric Pump Market in Global by Indication (2022-2032)
  • Figure 6: Elastomeric Pump Market in Global by End-User (2022-2032)
  • Figure 7: Elastomeric Pump Market in Global by Geography (2022-2032)
  • Figure 8: Elastomeric Pump Market in North America (2022-2032)
  • Figure 9: Elastomeric Pump Market in the United States (2022-2032)
  • Figure 10: Elastomeric Pump Market in Canada (2022-2032)
  • Figure 11: Elastomeric Pump Market in Mexico (2022-2032)
  • Figure 12: Elastomeric Pump Market in Europe (2022-2032)
  • Figure 13: Elastomeric Pump Market in France (2022-2032)
  • Figure 14: Elastomeric Pump Market in Germany (2022-2032)
  • Figure 15: Elastomeric Pump Market in United Kingdom (2022-2032)
  • Figure 16: Elastomeric Pump Market in Italy (2022-2032)
  • Figure 17: Elastomeric Pump Market in Spain (2022-2032)
  • Figure 18: Elastomeric Pump Market in the Rest of Europe (2022-2032)
  • Figure 19: Elastomeric Pump Market in Asia-Pacific (2022-2032)
  • Figure 20: Elastomeric Pump Market in China (2022-2032)
  • Figure 21: Elastomeric Pump Market in Japan (2022-2032)
  • Figure 22: Elastomeric Pump Market in India (2022-2032)
  • Figure 23: Elastomeric Pump Market in Australia (2022-2032)
  • Figure 24: Elastomeric Pump Market in South Korea (2022-2032)
  • Figure 25: Elastomeric Pump Market in Rest of Asia-Pacific (2022-2032)
  • Figure 26: Elastomeric Pump Market in the Rest of the World (2022-2032)
  • Figure 27: Elastomeric Pump Market in the Middle East (2022-2032)
  • Figure 28: Elastomeric Pump Market in Africa (2022-2032)
  • Figure 29: Elastomeric Pump Market in South America (2022-2032)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Marker Opportunities
  • Figure 33: PORTER'S Five Force Analysis